A case of steroid-resistant nephrotic syndrome associated with systemic lupus erythematosus

Ito, I; Nishida, M; Morioka, S; Nozaki, T; Imamura, T; Morimoto, A; Akioka, S; Sugimoto, T; Hamaoka, K; Hosoi, H
June 2014
Lupus;Jun2014, Vol. 23 Issue 7, p703
Academic Journal
We report on an 11-year-old girl who developed steroid-resistant nephrotic syndrome (NS) at the onset of systemic lupus erythematosus (SLE), and clinical and renal histological findings suggested that her NS would be associated with SLE-related podocytopathy. Although initial treatment with intravenous pulse methylprednisolone was ineffective, following treatment with cyclosporine and an angiotensin receptor blocker was effective for her nephrotic proteinuria. She had developed posterior reversible encephalopathy syndrome (PRES), and mycophenolate mofetil (MMF) was started instead of cyclosporine. At present, 45 months after the onset, she is in remission of both NS and SLE. This case indicates that NS associated with SLE-related podocytopathy should be included in the spectrum of glomerulopathy accompanying SLE, also in the pediatric population.


Related Articles

  • Severe bone marrow failure associated with the use of alternating steroid with chlorambucil in lupus membranous nephropathy in Chinese. Wang, A.; Li, P.; Lai, F.; Chow, K.; Szeto, C.; Leung, C.; Lui, S. // Lupus;Apr2001, Vol. 10 Issue 4, p295 

    Severe pancytopenia associated with the use of alternating steroid with chlorambucil regimen was described in six patients with nephrotic syndrome secondary to lupus membranous nephropathy (WHO class V). We believe this is the first report describing the life-threatening degree of marrow...

  • Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome. Kawasaki, Yukihiko; Suzuki, Junzo; Takahashi, Ai; Isome, Masato; Nozawa, Ruriko; Suzuki, Hitoshi // Pediatric Nephrology;Jan2005, Vol. 20 Issue 1, p96 

    There have been reports of the use of mizoribine (MZB) oral pulse therapy for the treatment of systemic lupus erythematosus. We report its efficacy in a 9-year-old girl with steroid- and cyclosporine-dependent nephrotic syndrome (NS). The patient experienced relapses of NS when prednisolone was...

  • The treatment of lupus with cyclosporin A. Griffiths, B.; Emery, P. // Lupus;Mar2001, Vol. 10 Issue 3, p165 

    Cyclosporin is a potent immunosuppressive drug and is frequently used in the therapy of auto-immune diseases, including systemic lupus erythematosus (SLE). Few large studies have been performed using this drug in SLE patients. However, small uncontrolled studies of patients with SLE have shown...

  • Seronegative systemic lupus erythematosus: etiology of nephrotic syndrome and acute renal failure in early postpartum period. Ozdemir, F. N.; Elsurer, R.; Akcay, A.; Ozdemir, B. H.; Sezer, S.; Kuscu, E.; Haberal, M. // Lupus;2005, Vol. 14 Issue 8, p629 

    Systemic lupus erythematosus (SLE) is an autoimmune syndrome that occurs most commonly in women during their reproductive years. Nephritis is known to be one of the most serious complications of SLE. Lupus nephropathy is frequently associated with ANA and anti-dsDNA antibodies. Rarely,...

  • Case Report of Pancreatic Pseudocyst in a Patient with Systemic Lupus Erythematosus. Chittal, Ramachandra; Williams, Akintunde; Field, Mel; Adjepong, S.; Sigurdsson, Auden // Internet Journal of Surgery;2009, Vol. 18 Issue 2, p7 

    Introduction: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disorder that has a wide range of clinical manifestations. Pancreatitis and pancreatic pseudocysts are known complications associated with the disease or attributed to the drugs used in treating SLE. Diagnosis and...

  • Late-onset systemic lupus erythematosus-associated liver disease. Schiavon, Leonardo; Carvalho-Filho, Roberto; Narciso-Schiavon, Janaína; Lanzoni, Valéria; Ferraz, Maria; Silva, Antonio // Rheumatology International;Sep2012, Vol. 32 Issue 9, p2917 

    Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease, which predominantly affects women under 50 years old. Although liver disease is not included in the diagnostic criteria, abnormal liver tests are common among patients with SLE and, in a significant proportion of those...

  • Multiple avascular necrosis in a patient with systemic lupus erythematosus/systemic sclerosis overlap syndrome. Cavallasca, Javier Alberto; Laborde, Hugo Armando; Araujo, Mariela Beatriz; Nasswetter, Gustavo Guillermo // Clinical Rheumatology;Aug2005, Vol. 24 Issue 4, p406 

    A white female patient developed overlapping features of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) with severe pulmonary compromise. She was treated with steroids and azathioprine, which improved her clinical condition and spirometric status. In May 2002 she presented with...


    An abstract of the article "Improvement in Bone Mineral Density (BDM)in Steroid-treated Systemic Lupus Erythematosus (SLE) Patients During Treatment With Prasterone (ASLERA)" is presented. Results of the study indicated that Prasterone prevents loss in BMD and increases bone mineral density in...

  • Systemic lupus erythematosus presenting as congenital nephrotic syndrome. Dudley, Jan; Fenton, Theo; Unsworth, Joe; Chambers, Timothy; MacIver, Angus; Tizard, Jane // Pediatric Nephrology;1996, Vol. 10 Issue 6, p752 

    A male Caucasian infant developed nephrotic syndrome at 10 weeks of age. He had high titres of anti-nuclear antibody (ANA) and anti-double-stranded DNA antibody, with hypocomplementaemia, antiplatelet antibodies and anticardiolipin antibodies. There were no detectable antibodies to extractable...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics